Mirae Asset Global ETFs Holdings
PVLA

Mirae Asset Global ETFs Holdings’s Palvella Therapeutics PVLA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$570K Buy
4,688
+382
+9% +$39.8K ﹤0.01% 1825
2025
Q4 		$446K Buy
4,306
+1,132
+36% +$96.6K ﹤0.01% 1947
2025
Q3 		$199K Sell
3,174
-576
-15% -$25.7K ﹤0.01% 2322
2025
Q2 		$84.5K Buy
+3,750
New +$88K ﹤0.01% 2691

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PVLA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Palvella Therapeutics (PVLA) stake by 8.9% in Q1 2026, buying an estimated $39.8K and bringing the position to 4,688 shares worth $570K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Mirae Asset Global ETFs Holdings first reported a position in PVLA in Q2 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 4,688 shares of Palvella Therapeutics worth $570K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 382 Palvella Therapeutics shares in Q1 2026, an estimated $39.8K.
  • Palvella Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1825 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Palvella Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.